Search »
- Use quotation marks (e.g., "RSR Manual") to search for exact phrases.
- You must be logged in to search for people in the Ryan White/TargetHIV community.
Content type
Topic Areas
Source
Publication Date
-
Overview of implementation science activities for the Ryan White HIV/AIDS Program (RWHAP) and feedback on future directions.News Article updated on 04/14/2023
-
Use of RWHAP Funds for Health Care Coverage Costs
Overview of RWHAP payment for clients’ health care coverage costs (insurance assistance).Resource updated 09/19/2023
-
Medical Home for Multiply Diagnosed HIV-Positive Homeless Populations
The RWHAP Part F SPNS program funded the Building a Medical Home for Multiply Diagnosed HIV-Positive Homeless Populations initiative from 2012–2017, to provide coordinated housing supports and HIV, behavioral and mental health care to people experiencing homelessness. Nine funded demonstration sites created partnerships with housing providers, integrated behavioral health and HIV care, and provided intensive patient navigator services. A multi-demonstration site evaluation found that, compared to baseline, participants were more likely to be virally suppressed after 12 months in the intervention.Resource from the RWHAP Best Practices Compilation updated on 11/13/2023
-
SPNS Initiative: Accelerating Implementation of Long-Acting Injectables (2022-2026)
-
Hosting a CAREWare Network
Options for outlining roles and responsibilities in hosting a CAREWare network as part of the planning process.Resource updated 09/19/2023
-
EHE in Focus
Tools to provide reporting guidance for recipients and providers that receive Ending the HIV Epidemic (EHE) Initiative funding.Resource updated 04/03/2024
-
EHE In Focus: Data Reporting Requirements for EHE-Funded Providers
Outline of data reporting requirements for RWHAP recipients and providers receiving Ending the HIV Epidemic funding.Resource updated 04/03/2024
-
Simplifying Salvage Antiretroviral Regimens in Treatment-Experienced PLWH
In a single-center restrospective cohort study, patients with extensive treatment experience and history of virologic failure and multi-drug resistance underwent simplification of ARV salvage regimens with a median pill burden reduction of six pills per day. This strategy led to high rates of virologic suppression.
Resource (Conference Presentation) updated 09/14/2023
-
HIV Clinic Staff and Community Perspectives on Long-Acting Injectable ART in New York City
The first long-acting injectable antiretroviral therapy (LAI ART) formulation was FDA-approved January 2021. Drawing on the Consolidated Framework on Implementation Research, this mixed methods study assessed knowledge, attitudes, practices, and perceived barriers and facilitators related to implementation of LAI ART in NYC among HIV clinic staff and people with HIV.
Resource (Conference Presentation) updated 09/14/2023
-
Promising Practices: The Impact of COVID-19 Related Policy Changes On Enrollment Capacity Within California's ADAP
California’s AIDS Drug Assistance Program (ADAP) and Pre-Exposure Prophylaxis Assistance Program (PrEP-AP) provide access to life-saving medications and insurance assistance for eligible California residents living with or at risk of acquiring HIV. This presentation will explore the efficacy of various program policy changes implemented by California during the COVID-19 pandemic.
Resource (Conference Presentation) updated 09/14/2023
-
Assessing Medication Access Barriers in Patients Living with HIV
Virginia quality improvement program that identifies access to medication barriers and provides emergency medication supplies to people with HIV if no timely access is secured.
Resource (Conference Presentation) updated 09/14/2023
-
Community Co-Creation: Engaging Traditional and Nontraditional Partners in a National Viral Suppression Campaign
HHS process for development of the “I Am a Work of ART” viral suppression campaign, in collaboration with community partners. of the National HIV/AIDS Strategy.
Resource (Conference Presentation) updated 09/14/2023
-
EHE In Focus: EHE Triannual Provider Report Validations
Summary of the validation checks initiated in the Ending the HIV Epidemic (EHE) Triannual Provider Report.Resource updated 10/17/2023
-
EHE Triannual Provider Report Data Validations
Review of validation checks in the EHE Triannual Provider Report that look for accuracy of data.Resource updated 10/04/2023
-
RWHAP Part B Supplemental PTR Manual
Instructions on how (RWHAP Part B Supplemental recipients can access, complete, and submit the RWHAP Part B Supplemental Program Terms Report (PTR).Resource updated 06/27/2024
-
Non-Competing Continuation RWHAP Part B/ADAP (X07): FY24 NCC Progress Report Submission
Instructions and resources for completing and submitting the FY 2024 Ryan White HIV/AIDS Program (RWHAP) Part B Non-Competing Continuation Progress Report.Resource updated 10/10/2023
-
RWHAP Program Letter: ADAPs and SUD Medications
On May 11, HRSA’s HIV/AIDS Bureau released a program letter encouraging RWHAP ADAP recipients to include medications for SUDs, including buprenorphine for OUD, and naloxone for opioid overdose prevention, on ADAP formularies.News Article updated on 05/15/2023 -
Long-Acting Injectables for HIV Antiretroviral Therapy
Guide for EHE jurisdictions on what they can do to enhance implementation of long-acting injectable antiretroviral therapy.Resource updated 04/12/2024
-
STI Implementation Plan Released
HHS has released an implementation plan on specific actions for entities to take in preventing and treating sexually transmitted infections (STI).News Article updated on 06/13/2023 -
RWHAP Part B Supplemental Expenditures Report Manual
Instructions on how RWHAP) Part B Supplemental recipients can access, complete, and submit the RWHAP Part B Supplemental Expenditures Report.Resource updated 06/27/2024